Bioxcel Corp - Net Worth and Insider Trading

Bioxcel Corp Net Worth

The estimated net worth of Bioxcel Corp is at least $988,646 dollars as of 2025-04-24. Bioxcel Corp is the 10% Owner of BioXcel Therapeutics Inc and owns about 534,172 shares of BioXcel Therapeutics Inc (BTAI) stock worth over $988,646. Details can be seen in Bioxcel Corp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bioxcel Corp has not made any transactions after 2021-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Bioxcel Corp

To

Bioxcel Corp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bioxcel Corp owns 1 companies in total, including BioXcel Therapeutics Inc (BTAI) .

Click here to see the complete history of Bioxcel Corp’s form 4 insider trades.

Insider Ownership Summary of Bioxcel Corp

Ticker Comapny Transaction Date Type of Owner
BTAI BioXcel Therapeutics Inc 2021-06-25 10 percent owner

Bioxcel Corp Latest Holdings Summary

Bioxcel Corp currently owns a total of 1 stock. Bioxcel Corp owns 534,172 shares of BioXcel Therapeutics Inc (BTAI) as of June 25, 2021, with a value of $988,646.

Latest Holdings of Bioxcel Corp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BTAI BioXcel Therapeutics Inc 2021-06-25 534,172 1.85 988,646

Holding Weightings of Bioxcel Corp


Bioxcel Corp Form 4 Trading Tracker

According to the SEC Form 4 filings, Bioxcel Corp has made a total of 1 transactions in BioXcel Therapeutics Inc (BTAI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in BioXcel Therapeutics Inc is the sale of 29,578 shares on June 25, 2021, which brought Bioxcel Corp around $15 Million.

Insider Trading History of Bioxcel Corp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bioxcel Corp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bioxcel Corp Ownership Network

Ownership Network List of Bioxcel Corp

No Data

Ownership Network Relation of Bioxcel Corp

Insider Network Chart

Bioxcel Corp Owned Company Details

What does BioXcel Therapeutics Inc do?

Who are the key executives at BioXcel Therapeutics Inc?

Bioxcel Corp is the 10 percent owner of BioXcel Therapeutics Inc. Other key executives at BioXcel Therapeutics Inc include Chief Financial Officer Richard I Steinhart , Chief Scientific Officer Frank Yocca , and director & CEO & President & Secretary Vimal Mehta .

BioXcel Therapeutics Inc (BTAI) Insider Trades Summary

Over the past 18 months, Bioxcel Corp made no insider transaction in BioXcel Therapeutics Inc (BTAI). Other recent insider transactions involving BioXcel Therapeutics Inc (BTAI) include a net sale of 1,439,995 shares made by Vimal Mehta , a net sale of 9,549 shares made by Richard I Steinhart , and a net sale of 9,399 shares made by Frank Yocca .

In summary, during the past 3 months, insiders sold 0 shares of BioXcel Therapeutics Inc (BTAI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 92,617 shares of BioXcel Therapeutics Inc (BTAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 92,617 shares.

BioXcel Therapeutics Inc (BTAI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioXcel Therapeutics Inc Insider Transactions

No Available Data

Bioxcel Corp Mailing Address

Above is the net worth, insider trading, and ownership report for Bioxcel Corp. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Bioxcel Corp's mailing address is: Guilford Ct 06437.